US 6,789,148 C14

GPTKB entity

Statements (75)
Predicate Object
gptkbp:instanceOf patent
gptkbp:covers chemical composition
gptkbp:hasAbstract This patent describes a novel method.
gptkbp:hasAssignee Company XYZ
gptkbp:hasClaim 20
composition of matter.
method of synthesis.
method of delivery.
method of treatment.
pharmaceutical formulation.
gptkbp:hasContent US_5,678,901
gptkbp:hasDescription Detailed description of the invention.
gptkbp:hasFieldOfUse medical devices
pharmaceuticals
biotechnology.
therapeutics.
gptkbp:hasFilingDate 2004-02-06
gptkbp:hasInternationalClassification C07D 401/12
gptkbp:hasInventor gptkb:John_Doe
Jane_Smith
gptkbp:hasLegalStatus gptkb:XYZ_Inc.
gptkb:XYZ_Corp.
active
active.
active patent.
XYZ_Corporation.
gptkbp:hasPatentNumber 6,789,148
gptkbp:hasPriorityDate 2024-02-06
2003-02-06
2003-02-06.
gptkbp:hasPublications 2004-09-14
gptkbp:hasRelatedPatent gptkb:US_6,789,147
granted patent
US_6,789,150.
US_6,789,149.
gptkbp:hasTechnicalField organic chemistry
medicinal chemistry.
pharmaceutical chemistry.
gptkbp:hasTechnology improved efficacy
enhanced stability.
improved absorption.
https://www.w3.org/2000/01/rdf-schema#label US 6,789,148 C14
gptkbp:isAssignedTo gptkb:XYZ_Corp.
gptkbp:isCitedBy gptkb:US_7,123,456
gptkb:US_7,890,123
US_7,890,123.
US_8,765,432.
gptkbp:isCitedIn gptkb:US_8,765,432
gptkb:US_9,876,543
US_9,876,543.
gptkbp:isExaminedBy gptkb:USPTO
patent office.
patent examiner.
USPTO.
USPTO_examiner.
gptkbp:isFiledIn gptkb:United_States
international patent office.
gptkbp:isFiledUnder gptkb:John_Doe
utility patent
patent law.
utility patent law.
Jane_Smith.
John_Smith.
gptkbp:isGranted true
gptkbp:isPartOf patent portfolio
patent family
intellectual property.
patent litigation.
patent strategy.
gptkbp:isPublishedIn USPTO database
patent journal
gptkbp:isRelatedTo gptkb:US_6,789,147
gptkb:US_6,789,150
US_6,789,149
gptkbp:relatedTo method for manufacturing